XML 20 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Operating Activities of Continuing Operations      
Net earnings $ 811,665 $ 508,892 $ 869,829
Adjustments to reconcile net earnings to cash from operating activities:      
Earnings from discontinued operations, net 0 0 (273,948)
Depreciation and amortization 394,240 360,739 327,089
Stock-based compensation 26,528 21,015 30,697
Gain on sale of businesses (203,138) (96,598) 0
Provision for losses on accounts receivable (net of recoveries) 11,295 10,641 5,946
Deferred income taxes (170,859) (79,414) (5,916)
Employee benefit plan expense 13,238 26,492 34,253
Contributions to employee benefit plans (20,464) (25,691) (21,942)
Other, net (52,108) (34,718) (2,258)
Cash effect of changes assets and liabilities (excluding effects of acquisitions, dispositions and foreign exchange):      
Accounts receivable (104,706) (44,649) 37,916
Inventories (12,557) 25,858 63,129
Prepaid expenses and other assets (11,136) 2,589 (7,401)
Accounts payable 124,051 58,695 42,925
Accrued compensation and employee benefits 29,059 (12,596) (71,090)
Accrued expenses and other liabilities (34,234) 45,371 (19,765)
Accrued taxes 20,685 95,349 (60,405)
Net cash provided by operating activities of continuing operations 821,559 861,975 949,059
Investing Activities of Continuing Operations      
Additions to property, plant and equipment (196,735) (165,205) (154,251)
Acquisitions (net of cash and cash equivalents acquired) (36,031) (1,561,737) (567,843)
Proceeds from the sale of property, plant and equipment 15,322 17,749 14,604
Proceeds from the sale of businesses 372,666 206,407 689,314
Settlement of net investment hedge 0 0 (17,752)
Other 21,151 (1,057) 1,350
Net cash provided by (used in) investing activities of continuing operations 176,373 (1,503,843) (34,578)
Financing Activities of Continuing Operations      
Proceeds from long-term debt 0 656,399 394,300
Proceeds from exercise of share-based awards, including tax benefits 0 8,431 4,024
Change in commercial paper and notes payable, net (183,194) 254,834 (327,000)
Repayment of long-term debt 0 (2,017) (300,048)
Dividends to stockholders (283,959) (268,339) (257,969)
Purchase of common stock (105,023) 0 (600,164)
Payments for employee tax obligations upon exercise of share-based awards (18,443) (15,700) (5,029)
Other (4,120) 0 0
Net cash provided by (used in) financing activities of continuing operations (594,739) 633,608 (1,091,886)
Cash Flows from Discontinued Operations      
Net cash (used in) provided by operating activities of discontinued operations 0 0 (113,946)
Net cash used in investing activities of discontinued operations 0 0 (1,984)
Net cash (used in) provided by discontinued operations 0 0 (115,930)
Effect of exchange rate changes on cash and cash equivalents 1,625 (4,779) (26,061)
Net decrease in cash and cash equivalents 404,818 (13,039) (319,396)
Cash and cash equivalents at beginning of period 349,146 362,185 681,581
Cash and cash equivalents at end of period 753,964 349,146 362,185
Supplemental information - cash paid during the year for [Abstract]      
Income taxes 337,987 170,394 346,382
Interest $ 140,863 $ 131,184 $ 128,151